Trademark Overview
On Monday, July 29, 2024, a trademark application was filed for NEUROPHARMAGEN with the United States Patent and Trademark Office. The USPTO has given the NEUROPHARMAGEN trademark a serial number of 98671767. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, July 29, 2024. This trademark is owned by PRECISION MOLECULAR SOLUTIONS LLC. The NEUROPHARMAGEN trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Medical services; Medical diagnostic services; Medical analysis services; Genetic testing for medical purposes; Performing diagnosis of diseases; Medical analysis for the diagnosis and treatment of persons; Remote monitoring of medical data for medical diagnosis and treatment; Genetic analysis in order to increase the efficiency of treatments for patients for medical purposes; Services for the preparation of medical reports; Information, advice and consultancy regarding all aforementioned services
Software as a service; Platform as a Service [PaaS]; Science and technology services; Genetic research; Genetic mapping for scientific purposes; Genetic testing for scientific research purposes; Medical and pharmacological research services; Design and development of medical technology; Design and development of computer software for use with medical technology; Pharmaceutical products development; Laboratory analysis; Clinical trials; Structural and functional anaylisis of genomes; Research in the field of pharmacogenetics; Information, advice and consultancy regarding all aforementioned services
